Kim Myung-Ho, Ahn Subin, Hur Nayeon, Oh Seung-Yun, Son Chang-Gue
Liver and Immunology Research Center, Daejeon Korean Medicine Hospital of Daejeon University, Daejeon, Republic of Korea.
Department of Internal Korean Medicine, Woosuk University Medical Center, Jeonju, Republic of Korea.
Front Pharmacol. 2024 Feb 23;15:1362391. doi: 10.3389/fphar.2024.1362391. eCollection 2024.
Non-alcoholic fatty liver disease (NAFLD) is difficult to manage because of its complex pathophysiological mechanism. There is still no effective treatment other than lifestyle modification (LM) such as dietary modifications, regular physical activity, and gradual weight loss. Herbal medicines from traditional Chinese Medicine and Korean Medicine have been shown to be effective in the treatment of NAFLD based on many randomized controlled trials. This systematic review and meta-analysis aims to evaluate the additive effects of herbal medicines on LM in the treatment of NAFLD. Two databases (PubMed and Cochrane library) were searched using keywords related to NAFLD and herbal medicines. Then the randomized controlled trials (RCTs) evaluating the therapeutic effects of herbal medicines combined with LM were selected. The pooled results were analyzed as mean difference (MD) with 95% confidence interval (CI) for continuous data, and risk ratio (RR) with 95% CI for dichotomous data. Eight RCTs with a total of 603 participants were included for this review study. Participants were administered with multi-herbal formulas (Yiqi Sanju Formula, Tiaogan Lipi Recipe, and Lingguizhugan Decoction) or single-herbal extracts (Glycyrrhiza glabra L., Magnoliae offcinalis, Trigonella Foenum-graecum L. semen, Portulaca oleracea L., and Rhus Coriaria L. fructus) along with LM for 12 weeks. The meta-analysis showed a significant improvement in ultrasoundbased liver steatosis measured by odds ratio (OR) in the herbal medicine group than those with LM alone (OR = 7.9, 95% CI 0.7 to 95.2, < 0.1). In addition, herbal medicines decreased the levels of aspartate transferase (MD -7.5, 95% CI -13.4 to -1.7, = 0.01) and total cholesterol (MD -16.0, 95% CI -32.7 to 0.7, = 0.06) more than LM alone. The meta-analysis partially showed clinical evidence supporting the additive benefits of herbal medicines for NAFLD in combination with LM. Whereas, it is necessary to provide a solid basis through higher-quality studies using a specific herbal medicine.
非酒精性脂肪性肝病(NAFLD)因其复杂的病理生理机制而难以管理。除了生活方式改变(LM),如饮食调整、定期体育活动和逐渐减重外,目前仍没有有效的治疗方法。基于许多随机对照试验,来自中医和韩医的草药已被证明在治疗NAFLD方面有效。本系统评价和荟萃分析旨在评估草药在NAFLD治疗中对生活方式改变的附加作用。使用与NAFLD和草药相关的关键词检索了两个数据库(PubMed和Cochrane图书馆)。然后选择评估草药联合生活方式改变治疗效果的随机对照试验(RCT)。汇总结果分析为连续数据的平均差(MD)及95%置信区间(CI),二分数据的风险比(RR)及95%CI。本综述研究纳入了8项随机对照试验,共603名参与者。参与者接受多种草药配方(益气散聚方、调肝理脾方和苓桂术甘汤)或单一草药提取物(光果甘草、厚朴、胡芦巴籽、马齿苋和盐肤木果实)联合生活方式改变治疗12周。荟萃分析显示,与单纯生活方式改变组相比,草药组基于超声的肝脂肪变性通过优势比(OR)衡量有显著改善(OR = 7.9,95%CI 0.7至95.2,P < 0.1)。此外,与单纯生活方式改变相比,草药降低了天冬氨酸转氨酶水平(MD -7.5,95%CI -13.4至-1.7,P = 0.01)和总胆固醇水平(MD -16.0,95%CI -32.7至0.7,P = 0.06)。荟萃分析部分显示了支持草药联合生活方式改变对NAFLD有附加益处的临床证据。然而,有必要通过使用特定草药的高质量研究提供坚实的依据。